Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-02 | Ms. Raines earned a bachelors degree in mathematics from Bowdoin College and an M.B.A. from the University of Chicago. |
| 2020-03-30 | Ms. Raines received a Bachelor’s Degree in Mathematics from Bowdoin College, in 1977. |
| 2021-04-01 | Ms. Raines received a Bachelor’s Degree in Mathematics from Bowdoin College and an MBA from the University of Chicago. |
| Filing Date | Source Excerpt |
|---|---|
| 2013-03-22 | Ms. Raines has served as Chief Financial Officer of IDEXX Laboratories, Inc. since October 2003. Prior to becoming Chief Financial Officer, Ms. Raines held several management positions with IDEXX, including Corporate Vice President of Finance, Vice President and Treasurer of Finance, Director of Finance, and Controller. IDEXX Laboratories develops, manufactures and distributes diagnostic and information technology based products and services for companion animal, livestock, poultry, water quality and food safety, and human point-of-care diagnostics. Skills and Qualifications. Ms. Raines' skills and qualifications to serve on our Board include her extensive financial and accounting experience with a similarly sized international manufacturing company. |
| 2014-03-25 | Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. ... Ms. Raines' skills and qualifications to serve on our Board include her extensive financial and accounting experience with a similarly sized international manufacturing company. 2013 DIRECTOR COMPENSATION table shows total $149,971. |
| 2015-03-26 | Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013. Ms. Raines also served as Executive Vice President of IDEXX from July 2012 until her retirement in May 2013. Prior to becoming Chief Financial Officer, Ms. Raines held several management positions with IDEXX, including Corporate Vice President of Finance, Vice President and Treasurer of Finance, Director of Finance, and Controller. IDEXX Laboratories develops, manufactures and distributes diagnostic and information technology based products and services for companion animal, livestock, poultry, water quality and food safety, and human point-of-care diagnostics. Ms. Raines is a member of the Board of Directors of Aratana Therapeutics, Inc., a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals. Ms. Raines is also a member of the Board of Directors of Affymetrix, Inc., a provider of life science and molecular diagnostic products that enable analysis of biological systems at the gene, protein and cell level. |
| 2016-03-31 | Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013. ... Ms. Raines' skills and qualifications to serve on our Board include her extensive financial and accounting experience with a similarly sized international manufacturing company. 2015 DIRECTOR COMPENSATION table shows total compensation of $175,519. |
| 2017-03-29 | Merilee Raines Age: 61 Director since: 2011 Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013. ... Ms. Raines' skills and qualifications to serve on our Board include her extensive financial and accounting experience with a similarly sized international manufacturing company. |
| 2018-03-23 | Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013. ... Ms. Raines' skills and qualifications to serve on our Board include her extensive financial and accounting experience with a similarly sized international manufacturing company and her public company board experience. ... Audit Committee Members: Merilee Raines, Chairperson, David A. Dunbar, Joseph W. Reitmeier. ... 2017 DIRECTOR COMPENSATION ... Merilee Raines 90,000 Fees Earned or Paid in Cash, 99,867 Stock Awards, 189,867 Total. |
| 2020-03-23 | Merilee Raines Age: 64 Director since: 2011 Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013. ... The Audit Committee's responsibilities also include: the appointment and evaluation of our independent registered public accounting firm; ... Audit Committee members receive and review materials in advance of each meeting. ... Nominating and Corporate Governance Committee members receive and review materials in advance of each meeting. |
| 2022-03-23 | Merilee Raines Age: 66 Director since: 2011 ...The following table contains information on compensation for the non-employee members of our Board of Directors during the fiscal year ended December 31, 2021. 2021 DIRECTOR COMPENSATION Name Merilee Raines Fees Earned or Paid in Cash ($) 95,000 Stock Awards ($)(1) 120,037 Total ($) 215,037 ...Audit Committee Merilee Raines, Chairperson ...Nominating and Corporate Governance Committee members Merilee Raines |
| 2023-03-28 | Merilee Raines Age: 67 Director since: 2011 Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013. 2022 DIRECTOR COMPENSATION Name Fees Earned or Paid in Cash ($) Stock Awards ($)(1) Total ($) Merilee Raines 100,000 141,835 241,835 COMMITTEE MEMBERS Audit Committee: Merilee Raines, Chairperson Governance and Sustainability Committee: Merilee Raines |
| 2024-04-01 | Merilee Raines Age: 68 Director since: 2011 Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013... The Audit Committee members include Merilee Raines, Rebecca J. Boll, David A. Dunbar, Joseph W. Reitmeier... The Governance and Sustainability Committee members include W. Craig Kissel (Chairperson), Rebecca J. Boll, Christopher L. Conway, Michael J. Dubose, David A. Dunbar, Louise K. Goeser, Kenneth Napolitano, Merilee Raines, Joseph W. Reitmeier... 2023 Director Compensation table shows Merilee Raines total compensation as $237,996. |
| 2025-04-01 | Ms. Raines served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013. Ms. Raines also served as Executive Vice President of IDEXX from July 2012 until her retirement in May 2013. Prior to becoming Chief Financial Officer, Ms. Raines held several management positions with IDEXX, including Corporate Vice President of Finance, Vice President of Finance and Treasurer, Director of Finance, and Controller. IDEXX Laboratories develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. Ms. Raines also served as a member of the board of directors of Aratana Therapeutics, Inc., a pet therapeutics company focused on licensing, developing and commercializing biopharmaceutical products for companion animals, from February 2014 until it was acquired in July 2019. Ms. Raines served as a member of the board of directors of Benchmark Electronics, Inc., a worldwide provider of engineering services, integrated technology solutions and electronic manufacturing services, from May 2018 to June 2021. Ms. Raines has served as a member of the board of directors of TransMedics Group, Inc., a medical technology company providing novel systems for the preservation and transport of organs to be used for transplant, since January 2021. Ms. Raines has also served as a member of the board of directors of Ocular Therapeutix, Inc., a biopharmaceutical company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye, since September 2021. |
Data sourced from SEC filings. Last updated: 2025-08-30